MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma.

Oncoimmunology · 2025 · PMC11881874 · PMID 40029206

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

showed a trendp = 0.058so close (0.05 < p ≤ 0.1)

Of note, MERTK expression in total myeloid cells showed a trend for positive correlation with total leukocytes ( p = 0.058), with a statistical significance for CD4 T-cells and TetOVA + CD8 T-cells ( Figure 4(b) ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.